Valuation: DBV Technologies

Market Cap 50Cr 56Cr 46Cr 42Cr 78Cr 5.33TCr 80Cr 551.82Cr 221.52Cr 2.81TCr 210.8Cr 206.32Cr 8.85TCr P/E 2026 *
-4.15x
P/E 2027 * -11.8x
Enterprise Value 44Cr 49Cr 40Cr 36Cr 68Cr 4.62TCr 69Cr 478.21Cr 191.97Cr 2.43TCr 182.68Cr 178.8Cr 7.67TCr EV / Sales 2026 *
116x
EV / Sales 2027 * 6.15x
Free-Float
99.85%
Yield 2026 *
-
Yield 2027 * -
1 day-6.59%
1 week-1.05%
Current month-18.03%
1 month-18.03%
3 months-28.75%
6 months-53.17%
Current year-49.70%
1 week 1.65
Extreme 1.651
1.92
1 month 1.53
Extreme 1.534
1.96
Current year 1.53
Extreme 1.534
4.4
1 year 1.53
Extreme 1.534
4.5
3 years 0.51
Extreme 0.506
4.5
5 years 0.51
Extreme 0.506
6.37
10 years 0.51
Extreme 0.506
86.64
Manager TitleAgeSince
Chief Executive Officer 66 29/11/2018
Director of Finance/CFO 56 06/11/2023
Chief Operating Officer - 01/12/2023
Director TitleAgeSince
Director/Board Member 51 21/10/2015
Director/Board Member 63 21/06/2016
Director/Board Member 60 15/06/2017
Date Insider Type Main position Quantity % Market Cap. Importance
29/07/26 Sell

Chief Technology Officer

-464 0.0002%
29/01/26 Sell

Chief Technology Officer

534 0.0003%
12/01/26
Baker Bros. Advisors LP
ExerciceCompany 5,46,09,792 27.1991%
Change 5-day change 1-year change 3-year change Capi.($)
-6.59%-1.05%-32.67%-18.58% 56Cr
+3.19%+11.31%+67.86%+150.58% 1,26300Cr
-0.73%+3.56%+44.51%+85.81% 66TCr
+1.41%+3.24%+29.22%+107.83% 52TCr
+0.42%+3.20%+54.15%+67.18% 39TCr
+2.18%+2.93%+73.30%+45.62% 37TCr
+1.12%+4.52%+35.30%+58.08% 31TCr
+6.96%+8.86%+11.27%+36.62% 29TCr
+1.15%+6.09%+59.59%+77.06% 25TCr
+3.06%+9.38%+44.11%+119.47% 21TCr
Average +0.90%+5.20%+38.66%+72.97% 42.62TCr
Weighted average by Cap. +1.19%+6.60%+50.87%+98.30%

Financials

2026 *2027 *
Net sales 37.45L 41.82L 34.45L 31.21L 58.35L 40Cr 59.44L 4.11Cr 1.65Cr 21Cr 1.57Cr 1.54Cr 66Cr 6.25Cr 6.97Cr 5.75Cr 5.21Cr 9.73Cr 662.17Cr 9.91Cr 69Cr 28Cr 348.32Cr 26Cr 26Cr 1.1TCr
Net income -19Cr -21Cr -18Cr -16Cr -30Cr -2.04TCr -30Cr -210.55Cr -85Cr -1.07TCr -80Cr -79Cr -3.38TCr -13Cr -14Cr -12Cr -11Cr -20Cr -1.34TCr -20Cr -138.36Cr -56Cr -703.42Cr -53Cr -52Cr -2.22TCr
Net Debt -6.71Cr -7.49Cr -6.17Cr -5.59Cr -10Cr -711.37Cr -11Cr -74Cr -30Cr -374.2Cr -28Cr -28Cr -1.18TCr -12Cr -13Cr -11Cr -9.92Cr -19Cr -1.26TCr -19Cr -130.59Cr -52Cr -663.95Cr -50Cr -49Cr -2.09TCr
Projected Income Statement - Annual - DBV Technologies
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
170
Date Price Change Volume
30/26/30 €1.700 -6.59% 12,22,127
29/26/29 €1.820 -4.51% 44,90,473
28/26/28 €1.906 +3.03% 11,25,330
27/26/27 €1.850 +3.24% 11,17,028
26/26/26 €1.792 +4.31% 9,85,485
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - DBV Technologies
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1.700EUR
Average target price
3.633EUR
Spread / Average Target
+113.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DBV Technologies